- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings
Patent holdings for IPC class A61K 31/4709
Total number of patents in this class: 5600
10-year publication summary
|
320
|
335
|
324
|
374
|
336
|
336
|
359
|
326
|
340
|
376
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 716 |
87 |
| Centre National de La Recherche Scientifique | 10666 |
62 |
| Janssen Pharmaceutica N.V. | 3350 |
60 |
| Bristol-myers Squibb Company | 4824 |
56 |
| The Regents of the University of California | 20268 |
53 |
| Boehringer Ingelheim International GmbH | 4637 |
51 |
| Arog Pharmaceuticals, Inc. | 53 |
49 |
| Vertex Pharmaceuticals Incorporated | 1621 |
45 |
| Gilead Sciences, Inc. | 2085 |
45 |
| F. Hoffmann-La Roche AG | 7934 |
44 |
| Institut Curie | 604 |
39 |
| Kura Oncology, Inc. | 122 |
39 |
| Universite de Montpellier | 1011 |
39 |
| Novartis AG | 10626 |
37 |
| Abivax | 122 |
36 |
| Merck Sharp & Dohme LLC | 3732 |
35 |
| Merck Patent GmbH | 5755 |
34 |
| Amgen Inc. | 4163 |
34 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 840 |
32 |
| Bayer Pharma AG | 1049 |
31 |
| Other owners | 4692 |